Lara Longpre is the chief development officer for Mirum, where she leads development operations, program management, and regulatory affairs.
Lara brings to Mirum more than 25 years of experience developing innovative and complex therapies, most recently as chief operating officer at MedGenesis Therapeutix and Jennerex Biotherapeutics where she held responsibilities for program management, alliance management, clinical operations, technical operations, regulatory affairs, and quality assurance. She previously held several leadership roles with PRA International and CroMedica including operations, regulatory affairs, and proposals & contracts.
Lara holds a B.A. in biology from Cornell University, a Master of Medical Science degree from Harvard Medical School, and an M.B.A. from Queen’s University in Ontario, Canada.